Showing posts with label VTYX. Show all posts
Showing posts with label VTYX. Show all posts
Monday, November 14, 2022
Thursday, October 21, 2021
Ventyx Biosciences (VTYX) began trading on the Nasdaq on Thur 21 Oct 21
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases.
- Sector(s): Healthcare
- Industry: Biotechnology
- Full Time Employees: 44
- Incorporated in 2018
- HQ: Encinitas, California
- https://ventyxbio.com
Ventyx Biosciences priced upsized 9,472,656 share IPO at $16/share, at the midpoint of the $15-17 expected range
Opened at $18.65
Subscribe to:
Posts (Atom)